Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.60USD
15 Feb 2019
Change (% chg)

$0.28 (+2.71%)
Prev Close
$10.32
Open
$10.37
Day's High
$11.14
Day's Low
$10.37
Volume
11,304
Avg. Vol
16,270
52-wk High
$19.00
52-wk Low
$5.57

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  SPRO.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -- -- --
ROI: -- 8.92 14.45
ROE: -- 10.08 15.96

Earnings vs. Estimates